The TECOS Trial of Sitagliptin vs Placebo

The TECOS Trial of Sitagliptin vs Placebo tecos TECOS was an event-driven study designed to assess the long-term CV safety of the addition of sitagliptin to usual care, compared to usual care tecos TECOS est une entreprise de services du numérique , spécialisée dans la transformation Digitale et la Data

tecos TECOS is a randomized, double-blind, controlled trial comparing sitagliptin and placebo when added to best usual care in patients with T2DM and cardiovascular

tecos 4PM for TECOS Slovenian tech center, fosters interdisciplinary collaboration for research and innovation across diverse fields Start, January 2016  Top-line results of the TECOS cardiovascular outcomes trial with sitagliptin indicate no increased risk of heart failure with the drug,